Member Info for Orange33

The TR1 is what has reduced the risk for me....there are only 2 reasons to add:

1) to buy votes to vote against it

2) they believe there is value here

If it were 1) they would've done so prior to the RNS a few days ago, which only leaves 2

Anything else, they would've bailed

Wouldnt be surprised to see a slow re-rate to 30-40p or so from here

All IMO

Can see this going 100% + soon, if a fund is happy to add to the TR1 then there must be life ....

Should really be 40p or so even without accredited

All IMO

The cash proceeds are worth over £1 per share....used to deleverage, but largely agree - should've remained neutral on announcement where it was 50 ish

IMO

Finally they speak out.... the MM's dropped it to 35p on announcement but somehow it had a freefall

Looking at the turnaround plan and deleveraging, it should still be in the high 30s IMO, been trading at the 50s most part of the year and hit nearly £2 a few years ago,

Dirt cheap for a punt

All IMO

Probably best to ignore the idiot, it's well oversold and at triple bottom, Berenberg are finally off the bid after months, they're funded until Q1 2025, remember this is a world beating FDA approved product which spiked to near £1.50 on approval with placees willing to pay 80p at the last raise, it'll get there again with one deal/good partnership IMO.

TwoGood2Die: looking at your posting history:

Rights Issue on the horizon31 Oct 2023 08:56

High cash burn rate and the requirements to meet ability to continue trading for than 12 months means a rights issue come Q1 next year!

Heading to sub 11p for obvious reasons..No Commercial Deals!1 Nov 2023 07:45

Lots of hype and expectations in the lead up to Christmas looking like delays and dissapointment looming on the horizon!

They did get it wrong and that's why it opened at £1.30 (40% down), which is arguably overdone for a still highly profitable 17% revenue fall

No reason for another 60% to be stacked onto it other than a big seller as per the prints

Any risk is double priced in already, just have some patience and stop scaremongering - its dirt cheap

All IMO

Ramping...? It's down 73% on a 17% revenue hit

In my experience, I tend to agree that 55p is the pin they're working at, no MM will absorb near 3m in shares and take it lower, once they're done with it, we should be back near opening price or the gap above it

All IMO

Read the IPO and trajectory, this has multibillion potential

All IMO

Yes the IPO was slightly over inflated, but readjusted itself to £2 or so....

This is a growth stock which had 9x% growth

Just look at the iniatitives too, stupid fall for a 17% revenue decline

I put this at around £1.60-£1.70

Will get there when the seller clears

All IMO DYOR

You do know this closed at 2300 and opened up at 1600 on a similar profit level? (yes there's debt etc, but the drop is WAY overdone IMO)

Now that the seller is out, 1500+ is not unreasonable at all

Historically pays around 80p+ of dividend so still a yield of 10% if it starts paying again, plus the 60% or so value drop, easy money

All IMO

Well there's the seller out.... massive print

Dividend cancelled, should do well today now back to £18 please

IMO

With operating profit for the year ended 31 December 2023 now expected to be broadly similar to last year.....

Storm in a teacup, give it time IMO

842 and then 730, but the support here is theoretically strong, so should reverse heavy if it curls up

IMO

Looks stupid cheap here, should be around £18 or so based on prior PEs

All IMO

Vaiter, suggest you go back to STX where investors have been absolutely fleeced and diluted into oblivion with an overhang that will take months to churn, leave OBD to us

Jealousy disguised as being our saviour is ugly, just like the STX chart

I'll leave this here: 200k capacity at £750 per test = £150m

Expanded production to 600k planned = £450m

Market opportunity 25m and 5m for USA and UK only

Don't you worry about the SP it'll hit the £s at some point.

All IMO

Been painful here, companies like OBD do premium raises and we get shafted here for 8p, how long does that take to flip?

Needs news for sure to churn the rest of it

IMO

Usually don't respond to knobs but:

1) New account TICK

2) Failed investment in another biotech TICK

3) Comes in and supposedly been around at 10p lows so I know it all TICK

4) first post after a monstrous rise warning people TICK

5) mentions funding and equity raise as if investors can't see reports or did we not raise a month ago? TICK

6) discredits the product by mentioning waffle as if he designed and validated the test, who knows though maybe the 10 years + oxford/nhs work are wrong TICK

7) Idiot TICK

If you have a basic understanding of GCSE math, you'll understand why the opportunity here far exceeds the current MCAP

All IMO

Spent the entire weekend researching this and peers/market prices etc, this could be a high multi billion mcap opportunity, one of those you see every 10 years or so

I think this should probably be sitting at £500m - £1bn mcap right now before further news, the market has no idea what we’re in for.

DYOR all IMO

It's simple, the reason you pay £300k at highest price of the day is because you think its worth many multiples of that, doesn't matter if it drops in the short term, with that sort of money you're probably expecting at least 10x on your investment especially on AIM stocks

IMO